Simulations Plus Subsidiary Receives Medicare Accreditation

Highest level of accreditation achieved after on-site inspection
LANCASTER, Calif.--(Business Wire)--
Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software for
pharmaceutical discovery and development, announced today that its wholly owned
subsidiary, Words+, Inc., has been accredited by Medicare.

CARF International, a Medicare appointed accreditation organization, announced
that Words+, Inc., has been awarded accreditation as a Medicare DMEPOS (Durable
Medical Equipment, Prosthetics, Orthotics, and Supplies) supplier in
augmentative communication and speech generating devices.

Jeff Dahlen, president of Words+, said, "We recently underwent an accreditation
audit during which CARF applied Medicare quality standards, examined our
manufacturing and service delivery procedures, and interviewed employees
involved in all aspects of the business. We are very pleased to announce
approval at the highest level available for Medicare accreditation. I am very
proud of our entire staff and distributor network."

Ms. Momoko Beran, chief financial officer for Simulations Plus, added: "Medicare
accreditation is required in order to provide products and services to Medicare
clients. Many companies are still struggling to meet this new critical
requirement by the September 30, 2009 deadline. Words+ also serves clients
funded by all fifty independent state Medicaid agencies, some of which already
require Medicare provider status in order to serve their clients. Other state
Medicaid agencies are expected to include this requirement soon because Medicare
accreditation ensures their clients receive high quality products and services
from stable, responsible companies. The independent insurance industry is
expected to follow suit. This extends the importance of Medicare accreditation
far beyond just being an authorized Medicare provider. Words+ is one of very few
companies providing service and funding support at this broad national level."

About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery
and development software, which is licensed to and used in the conduct of drug
research by pharmaceutical, biotechnology, and drug delivery companies
worldwide. The Company`s Words+ subsidiary, which provides assistive technology
for persons with disabilities, as well as two retail products, Abbreviate! and
FutureLab™, comprise the remainder of the business. Simulations Plus, Inc., is
headquartered in Southern California and trades on the NASDAQ under the symbol
"SLP." For more information, visit our Web site at www.simulations-plus.com.

About CARF

CARF is an independent, nonprofit accrediting body whose mission is to promote
the quality, value, and optimal outcomes of services through a consultative
accreditation process that centers on enhancing the lives of the persons served.
Founded in 1966 as the Commission on Accreditation of Rehabilitation Facilities,
and now known as CARF, the accrediting body establishes consumer-focused
standards to help organizations measure and improve the quality of their
programs and services.

Investor Relations
Simulations Plus, Inc.
Ms. Renée Bouché
661-723-7723
info@simulations-plus.com

Copyright Business Wire 2009